Expert Evaluation of Strategies to Modernize Newborn Screening in the United States

IMPORTANCE: Novel therapies, including cell and gene therapies, can radically improve outcomes among patients with rare disorders, especially if provided early. Newborn screening (NBS) could support early access to novel therapies, but the speed of new therapy development is a disruptive event for w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Donald B., Porter, Katherine Ackerman, Andrews, Sara M., Raspa, Melissa, Gwaltney, Angela Y., Peay, Holly L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717100/
https://www.ncbi.nlm.nih.gov/pubmed/34964853
http://dx.doi.org/10.1001/jamanetworkopen.2021.40998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717100/
https://www.ncbi.nlm.nih.gov/pubmed/34964853
http://dx.doi.org/10.1001/jamanetworkopen.2021.40998

Ejemplares similares